Invited Commentary

Commentary on "Edmonton Symptom Assessment System for Outpatient Symptom Monitoring of Sickle Cell Disease"

Authors: Albert S. Braverman, MD

Abstract

The application of the Edmonton Symptom Assessment System (ESAS) to patients with sickle cell disease (SCD) reporting to a dedicated clinic1 reveals and explicates symptoms other than pain. The study responds to the need for a more organized approach to SCD and supports the value of the tool by its account of patient responses. It is likely to be even more important in the care of patients who present to emergency departments and after admission. Hematologists are consulted, but care often is administered by emergency and general medical personnel, for whom a defined approach is important.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Lopez G, Liles DK, Knupp CL. Edmonton Symptom Assessment System for outpatient symptom monitoring of sickle cell disease. South Med J 2014;107:768-772.
 
2. Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood 2012;120:3647-3656.
 
3. Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012;30:880-887.